Solicitation, 8(a) set-aside
Post-Market Bioequivalence of Generic Drug Product
75F40124R00023
Food and Drug Administration, FDA Center for Drug Evaluation and Research. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
Response deadline
January 24, 2024 at 10:00 AM EST
Closed 967 days ago. Posted January 3, 2024, first published January 3, 2024. Scheduled to archive February 8, 2024.
Description
As published on SAM.gov.
Post-Market Bioequivalence of Generic Drug Product 01/03/2024- Amendment to provide the government's response to quesions and to provide a new proposal due date. Proposals are due 10AM EST 01/24/2024
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
Points of contact
- Telisha WIlsontelisha.wilson@fda.hhs.gov